Clik here to view.
Compliance News in “Preview”
As we wistfully wish 2016 a fond farewell, we welcome 2017 and wonder what compliance surprises, developments, and news the year might hold. What will be the hot topics debated around the water cooler...
View ArticleClik here to view.
Compliance News in Review, January 27, 2017
The Serious Fraud Office leads the charge on Rolls-Royce’s multi-jurisdictional bribery settlement; the FDA releases new draft guidance; and a new transparency law is on the way in Maine. While most...
View ArticleClik here to view.
So Many Anticorruption Laws, So Little Training Time
On January 12th, Zimmer Biomet reached a $30 million settlement with the Department of Justice and the Securities and Exchange Commission over business activities in Mexico. A few days later, an $800...
View ArticleClik here to view.
The Forgetting Curve and Compliance Training
What exactly does a 167-year-old German scientist have to do with your compliance training? As a chief compliance officer, or training manager, the answer may keep you up at night – especially if you...
View ArticleClik here to view.
Compliance News in Review, March 27, 2017
Everything’s coming up roses, off-label speech, and corruption, in this edition of the News in Review. We’ve got the fever…Spring fever! Spring has sprung, and we couldn’t be happier. Warmer weather,...
View ArticleClik here to view.
Move Beyond the Basics to Make Compliance Training Stick
We’ve come a long way in life sciences compliance training in a relatively short time. Fifteen years ago, the common approach to compliance training often involved lawyers from the legal department,...
View ArticleClik here to view.
Compliance News in Review, April 19, 2017
The city of Chicago releases sales representative licensure rules; review and dispute time is here again; opioid manufacturers receive letters and negotiate settlements; and Australia proposes changes...
View ArticleClik here to view.
Pharmaceutical Compliance Congress 2017 Preview
The 14th Annual Pharmaceutical Compliance Congress (PCC 2017) is just around the corner. Whether you work in Compliance, R&D, or Medical Affairs, this year’s conference has sessions for you. We’ll...
View ArticleClik here to view.
Notes from A Busy Day at CBI’s 14th Annual Pharmaceutical Compliance Congress
The 14th Annual Pharmaceutical Compliance Congress featured an array of industry leaders, regulators, and legal consultants offering best practices, tips, and first-hand experiences related to reducing...
View ArticleClik here to view.
Compliance News in Review, May 22, 2017
Insider trading baseball; PhRMA changes the rules; shorter FCPA investigations; praise for Medicines Australia transparency efforts; and a Chinese television drama all about anticorruption. The heat is...
View ArticleClik here to view.
Compliance News in Review, June 13, 2017
States with new laws, lawsuits and more; HHS says drug pricing is a top issue; the AMA takes aim at DTC ads again; and transparency efforts and more from Europe…all in this edition of the Compliance...
View ArticleClik here to view.
Compliance News in Review, July 7, 2017
Canadians, Californians, and Mainers are all on the hunt for transparency. Will they find “gold” they seek? Find out in this week’s News in Review. There’s gold in them thar hills! Seriously. A number...
View ArticleClik here to view.
Compliance News in Review, July 31, 2017
A whistleblower settlement, the effect of a recent cyberattack on one company’s drug supply, transparency in Ontario, and the growth of CME, all served for your approval in this edition of the...
View ArticleClik here to view.
Compliance News in Review, August 21, 2017
Opioid investigations expand; the FDA plans drug advertising studies; DOJ units team up for healthcare sector FCPA investigations; the Sunshine Act is out in South Korea; and a big settlement could...
View ArticleClik here to view.
Compliance News in Review, September 8, 2017
Attention students! This week in the news: an opioid marketing Warning Letter; more state level transparency requirementss; and Novo Nordisk learns a tough lesson about product marketing. The wheels on...
View ArticleClik here to view.
Compliance News in Review, September 22, 2017
Reprimands in the UK, opioid manufacturers face another investigatory group, and registration processes for Nevada representatives, all in this week’s Compliance News in Review. Ready or not, Fall is...
View ArticleClik here to view.
Top Ten Compliance Training Mistakes
With apologies to the recently unretired (and bearded) David Letterman, welcome to the first edition of the PharmaCertify Compliance Training Top Ten List. We’ve witnessed a range of missteps and...
View ArticleClik here to view.
Life Sciences Compliance Congress West: A Preview
CBI’s 8th Annual Life Sciences Compliance Congress West kicks off in San Francisco in two short weeks. During the packed two-day conference, an esteemed lineup of industry professionals and government...
View ArticleClik here to view.
The Do’s and Don’ts of Compliant Product Promotion
In keeping with our mission of helping you reduce risk and strengthen your compliance culture, we present our top do’s and don’ts for promoting products to healthcare professionals: Do…be balanced and...
View ArticleClik here to view.
Friday the 13th Brings Multiple Settlements for One Unlucky Company
CMS posts new Open Payments thresholds, MedTech Europe revises its Code, California deals with two new pharmaceutical laws, and multiple settlements are announced for one “unlucky” pharmaceutical...
View Article